Edit |   |
---|---|
Antigenic Specificity | CD20, Human (Ocaratuzumab biosimilar) |
Clone | Ocaratuzumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG1 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | Neut, ELISA, IF, IP, FuncS, FCM, ICC |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human CD20 Recombinant Antibody (Ocaratuzumab). Ocaratuzumab (AME-133v, LY2469298) is a humanized monoclonal antibody designed for the treatment of cancer and autoimmune disorders. The antibody is engineered for enhanced affinity to the CD20 antigen on B-lymphocytes, increased antibody-dependent cell-mediated cytotoxicity (ADCC), and for improved treatment of low-affinity Fc RIIIa allotypes. |
Immunogen | n/a |
Other Names | Anti-CD20 Recombinant Antibody, Research Grade Ocaratuzumab, Anti-Human CD20 Recombinant Antibody(Ocaratuzumab), AME-133v, LY2469298, Antibody Drug Analogues, Monoclonal Antibody, YR1285, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 1169956-08-4 |
Catalog # | YR1285 |
Price | please inquire |
Order / More Info | CD20, Human (Ocaratuzumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |